Dr. Leon S Kulinski, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 207 Center Street, Oil City, PA 16301 Phone: 814-676-2705 Fax: 814-676-2706 |
Dr. Douglas M Hutchinson, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 217 Sycamore St, Oil City, PA 16301 Phone: 814-670-0374 Fax: 814-670-0376 |
Dr. Thaddeus G. Zawislak Jr., D.M.D. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 161 E Bissell Ave, Oil City, PA 16301 Phone: 814-677-1341 Fax: 814-676-6627 |
Dr. Mark Andrew Hajduk, D.M.D. Dentist Medicare: Not Enrolled in Medicare Practice Location: 108 W 1st St, Oil City, PA 16301 Phone: 814-676-1836 |
Jonathan Mealy Dentist Medicare: Not Enrolled in Medicare Practice Location: 217 Sycamore St, Oil City, PA 16301 Phone: 814-670-0374 Fax: 814-670-0376 |
Dr. Samuel C Shialabba Jr., DMD Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 45 Seneca St, Suite 208, Oil City, PA 16301 Phone: 814-677-3025 Fax: 814-677-6766 |
Paul David Kerna, DMD Dentist Medicare: Medicare Enrolled Practice Location: 108 West First Street, Oil City, PA 16301 Phone: 814-676-1836 Fax: 814-676-3104 |
Dr. Robert L Deshong Ii, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 215 Petroleum St, Oil City, PA 16301 Phone: 814-676-6594 Fax: 814-676-8484 |
News Archive
Very few children are born with HIV in Thailand today. During the 1990s, the Thai government implemented a vast prevention programme in order to control the epidemic that was rife in the North of the country. The reduction of mother-to-child transmission was one of the major successes resulting from these measures. However, before this programme was established, numerous infants were born with the infection.
NVX-CoV2373 is produced by the biotech company, Novavax (Maryland, U.S.A). Novavax is a late-stage biotechnology company that develops next-generation vaccines for serious infectious diseases.
Arsenic is usually thought of as a poison. Despite this, it has been used in medicine for over 2000 years, and the arsenic compound arsenic trioxide (ATO) is FDA approved for the treatment of acute promyelocytic leukemia.
Merrimack Pharmaceuticals, Inc., a biopharmaceutical company discovering, developing and preparing to commercialize innovative medicines paired with companion diagnostics for the treatment of serious diseases, with an initial focus on cancer, today announced the pricing of its initial public offering of 14,300,000 shares of its common stock at $7.00 per share, before underwriting discounts and commissions. All of the shares in the offering are being sold by Merrimack.
› Verified 5 days ago